0001437749-15-016546.txt : 20150827 0001437749-15-016546.hdr.sgml : 20150827 20150827190908 ACCESSION NUMBER: 0001437749-15-016546 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150825 FILED AS OF DATE: 20150827 DATE AS OF CHANGE: 20150827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMPAX LABORATORIES INC CENTRAL INDEX KEY: 0001003642 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 650403311 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 BUSINESS PHONE: 510-240-6000 MAIL ADDRESS: STREET 1: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\ DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARKBREITER MICHAEL CENTRAL INDEX KEY: 0001025714 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34263 FILM NUMBER: 151079791 MAIL ADDRESS: STREET 1: BATTLE FOWLER LLP STREET 2: 75 EAST 55TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 rdgdoc.xml FORM 4 X0306 4 2015-08-25 0001003642 IMPAX LABORATORIES INC IPXL 0001025714 MARKBREITER MICHAEL C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544 1 Common Stock 2015-08-25 4 S 0 9399 41.67 D 8200 D Common Stock 2015-08-26 4 M 0 10000 6.55 A 18200 D Common Stock 2015-08-26 4 S 0 10000 42.78 D 8200 D Stock Option (Right to Buy) 6.55 2015-08-26 4 M 0 10000 0 D 2019-05-20 Common Stock 10000 0 D The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $40.88 to $42.64 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $41.65 to $43.46 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. 100% of the shares subject to the option are fully vested and exercisable. The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person. /s/ Mark A. Schlossberg, by Power of Attorney 2015-08-27